Doximity, Inc. (DOCS)
NYSE: DOCS · Real-Time Price · USD
62.92
-1.10 (-1.72%)
Aug 14, 2025, 12:45 PM - Market open

Doximity Revenue

Doximity had revenue of $145.91M in the quarter ending June 30, 2025, with 15.19% growth. This brings the company's revenue in the last twelve months to $589.64M, up 19.45% year-over-year. In the fiscal year ending March 31, 2025, Doximity had annual revenue of $570.40M with 19.98% growth.

Revenue (ttm)
$589.64M
Revenue Growth
+19.45%
P/S Ratio
20.35
Revenue / Employee
$710,405
Employees
830
Market Cap
11.78B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025570.40M94.98M19.98%
Mar 31, 2024475.42M56.37M13.45%
Mar 31, 2023419.05M75.50M21.98%
Mar 31, 2022343.55M136.65M66.05%
Mar 31, 2021206.90M90.51M77.76%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings